US Global Public Health Policy

Chris Coghlan Excerpts

Tuesday 11th February 2025 Commons Chamber

[Dr Chambers]

I thank the hon. Gentleman for his intervention. He makes a hugely important point.

Economic pressures demand efficiency, but let there be no doubt: withdrawing support from the World Health Organisation is a false and dangerous economy. By stepping away instead of seeking reforms from within, the US has thrown global health security into turmoil. This is about not just principles, but consequences. A withdrawal on this scale damages health diplomacy and erodes trust. It allows adversarial states to step in and use disinformation and strategic influence to reshape the global health landscape to their advantage. If the World Health Organisation is weakened, its ability to track, contain and fight disease is also weakened, and that makes us all more vulnerable. Other nations are already considering following suit; Argentina is voicing similar intentions. If more countries withdraw, we risk a domino effect that could collapse the framework we rely on to monitor and respond to health threats.

[Chris Coghlan (Dorking and Horley) (LD)]

My hon. Friend is making a powerful speech. Does he agree that one lesson from the pandemic is that the last thing countries should do is withdraw from organisations such as the World Health Organisation and reduce international co-operation, given the risk of a future pandemic at some point?

[Dr Chambers]

I could not agree more. My hon. Friend is completely right. The World Health Organisation is at the heart of international disease surveillance, co-ordinating early responses to outbreaks of deadly diseases such as Ebola and highly pathogenic avian influenza, both of which have been in the news in the last couple of weeks. In today’s interconnected world, speed is everything. Without robust early warning systems, outbreaks that might have been contained could spiral into pandemics, just as my hon. Friend said.

We also cannot ignore the worsening impact of climate change on global health. Due to changing temperatures, diseases that were classed as tropical when I was at university are now being seen in other parts of the world. The US withdrawal from the Paris agreement has already slowed efforts to tackle climate-driven diseases; now, its retreat from global health co-operation leaves us even less well prepared to handle the consequences. The UK must remain firm in supporting the WHO’s role in pandemic preparedness, not only because it is morally right, but because it is in our national interest.

This crisis affects more than just emergency outbreaks; it threatens our ability to manage persistent health threats here at home. Take seasonal flu. Every winter, the NHS faces immense pressure from influenza. Our ability to develop effective vaccines depends on international collaboration, including data from US research centres. If those partnerships are disrupted, how will we prepare for the 2025 flu season? The same applies to broader scientific research. The UK and US have worked closely on the One Health Initiative, studying how animal, human and environmental health intersect. Hundreds of these projects have now stalled, cutting off vital knowledge that could have helped us understand future pandemics. We must explore ways to sustain these collaborations. That includes securing funding for key research programmes and ensuring that our world-class universities remain engaged in global health security efforts. If we do not do those things, we risk falling behind in disease surveillance, vaccine development and pandemic preparedness.

I have spoken in this House before about the urgent threat of antibiotic-resistant infections to the NHS. Alongside the UK, the US has been a strong supporter of WHO-led efforts to tackle antimicrobial resistance, which experts warn is one of the greatest global health challenges of our time. Antibiotic resistance does not respect borders. Drug-resistant bacteria and fungi travel with people and goods across the world. Without global surveillance, the consequences will be dire. More people will die in NHS hospitals from infections that we can no longer treat. This is not a distant problem; it is happening now. The UK has been helping Ukraine tackle antimicrobial resistance worsened by war. Despite severe funding challenges, collaborations between Chelsea and Westminster hospital, Great Ormond Street hospital, University College London and Ukrainian institutions have made progress. This proves that even in difficult circumstances, proactive partnerships can make a difference. We must apply these lessons to protect our own health security. I pay tribute to the laboratory team and Professor Inada-Kim in our hospital in Winchester, who are helping to lead the national effort to tackle AMR in our NHS.

The UK has a proud history of leading on global health. It was here that Sir Alexander Fleming discovered penicillin, revolutionising modern medicine. Edward Jenner’s smallpox vaccine laid the foundation for immunisation efforts that have saved hundreds of millions of lives. British researchers helped eradicate rinderpest in cattle, the only other disease besides smallpox to be wiped out completely. Today, smallpox is gone. Rinderpest is gone. One day, we hope to say the same about polio, but that vision is now at risk. I recently visited the rotary club in Winchester and learned about the long involvement of rotary clubs worldwide in supporting polio eradication over a period of many years. The US withdrawal forces us to consider how we reaffirm our leadership in global health.